Suchergebnisse - "Sohbani, Navid"

PubPharm (4)

1

Ramucirumab as a second line therapy for advanced HCC : a significant achievement or a wasted opportunity for personalised therapy?

enthalten in: Investigational new drugs | 2019

von Roviello, G. | Sohbani, N. | Petrioli, R. | +1

2

Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?

enthalten in: Investigational new drugs | 2019

von Roviello, G. | Sohbani, N. | Petrioli, R. | +1

3

Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?

enthalten in: Investigational new drugs | 2019

von Roviello, G. | Sohbani, N. | Petrioli, R. | +1

4

Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?

enthalten in: Investigational new drugs | 2019

von Roviello, G. | Sohbani, N. | Petrioli, R. | +1

1
[1]